A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Clinical trial NCT02220855 · COMPLETED
Trial details
- NCT number
- NCT02220855
- Sponsor
- Patrick Joseph Loehrer Sr.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-03-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.